Abstract

DeVry Education will release its quarterly results on October 28, 2026 Post Market, with investor attention on revenue acceleration, margins, and adjusted EPS as consensus points to improving operating leverage and mixed enrollment trends.

Market Forecast

Consensus and company-derived projections indicate DeVry Education’s current quarter revenue at USD 0.49 billion, with year-over-year growth of 13.85%, forecast EBIT at USD 0.12 billion with year-over-year growth of 42.45%, and forecast adjusted EPS at USD 2.19 with year-over-year growth of 59.67%; margin expectations imply continued improvement, though specific gross and net margin forecasts were not disclosed. The main businesses are expected to benefit from sustained enrollment and program mix optimization, with operating efficiency improvements supporting margin continuity. The most promising segment is Walden University, with revenue of USD 0.19 billion last quarter and advancing growth driven by graduate nursing and health programs; year-over-year growth details for this segment were not provided.

Last Quarter Review

DeVry Education’s previous quarter delivered revenue of USD 0.46 billion, gross profit margin of 56.57%, GAAP net profit attributable to the parent company of USD 61.83 million, net profit margin of 13.38%, and adjusted EPS of USD 1.75, with year-over-year growth of 35.66% on adjusted EPS. A notable highlight was net profit growth of 14.06% quarter-on-quarter, signaling improving operating leverage and disciplined cost control. Main business contributions were led by Walden University at USD 0.19 billion, Chamberlain University at USD 0.18 billion, and the Medical and Healthcare segment at USD 0.09 billion, underscoring diversified program demand; year-over-year details by segment were not disclosed.

Current Quarter Outlook

Main Business Trajectory

Revenue mix is anchored by Walden University and Chamberlain University, which together comprise a substantial share of DeVry Education’s sales base. The expected revenue step-up to USD 0.49 billion, paired with a forecast EBIT of USD 0.12 billion, suggests improved operating leverage from ongoing cost efficiencies, academic program alignment, and enrollment stabilization. Margin sustainability hinges on course delivery efficiency, faculty utilization, and digital learning platform investments that help maintain the gross profit margin profile seen last quarter at 56.57%. Management’s balance between pricing discipline and student support services is likely to influence net margin resilience around last quarter’s 13.38%, though tuition promotions and financial aid dynamics could swing realized margins. Given the adjusted EPS forecast at USD 2.19, the market is bracing for a robust earnings inflection supported by cross-campus initiatives and retention gains.

Most Promising Growth Engine

Walden University appears positioned as the strongest near-term growth contributor, underpinned by graduate nursing, counseling, and health administration programs that align with employment demand. Its USD 0.19 billion revenue base last quarter provides a springboard for incremental growth as curricula expand and licensure-aligned offerings deepen. Competitive differentiation can emerge from online instructional design, student outcomes support, and recognition in professional communities, all of which tend to bolster enrollment funnels and cohort persistence. A tighter focus on academic advising and asynchronous delivery quality could strengthen conversion and retention, translating to higher revenue productivity even if price increases remain modest. While explicit year-over-year segment growth data was not provided, the broader company revenue forecast growth of 13.85% indicates room for Walden’s contribution to rise if program-level demand remains firm.

Stock Price Drivers This Quarter

The stock’s response will likely be most sensitive to enrollment trends across nursing and health programs, where seasonal patterns and cohort timing can skew quarterly metrics. Pricing stability and scholarship intensity are key, as they determine realized revenue per student and flow through to margins. Operating expense discipline—particularly within marketing, faculty cost, and student support—will shape EBIT realization relative to the forecast USD 0.12 billion. Any commentary about regulatory developments, accreditation milestones, or licensure pass-rate outcomes can reframe investor expectations for medium-term growth quality. Execution on technology-enabled course delivery, coupled with retention improvements, may reinforce the adjusted EPS path toward USD 2.19, while any mix shift toward lower-margin offerings could cap upside. Finally, updates on program pipeline, especially within healthcare and counseling, will be weighed against competitive dynamics in online higher education.

Analyst Opinions

The majority of institutional commentary leans constructive on DeVry Education’s near-term earnings profile, citing operating leverage and enrollment stability, with a minority cautioning about potential variability in student acquisition costs and regulatory sensitivity. Well-followed sell-side voices emphasize that the forecast revenue of USD 0.49 billion and adjusted EPS of USD 2.19 are attainable given recent execution and cost control, framing the setup as favorable if Walden and Chamberlain sustain their momentum. The optimistic view rests on margin continuity supported by last quarter’s 56.57% gross margin and improving net profit dynamics; analysts point to continued program mix alignment in healthcare and counseling as catalysts for both topline and earnings. Supportive commentary also flags that EBIT uplift to USD 0.12 billion would validate productivity improvements and reinforce cash generation, while attention remains on management’s narrative around enrollment quality and retention. Overall, the bullish camp expects the company to meet or slightly exceed internal forecasts if enrollment conversion holds and operating costs remain contained, with upside dependent on visibility into the healthcare education pipeline and clarity on any regulatory headwinds.